Skip to content
by Legal Desire
12 October 2026

Latham Advises on TRexBio’s US$116.7 Million Initial Public Offering

Advising firms

Deal team

17 lawyers named
LawyerFirmSeniorityPracticeOffice
Peter Handrinos Lead Latham & Watkins LLP Partner Capital Markets Not stated
Wesley Holmes Lead Latham & Watkins LLP Partner Capital Markets Not stated
Jennifer Yoon Lead Latham & Watkins LLP Partner Capital Markets Not stated
Emma Gilmore Latham & Watkins LLP Associate Capital Markets Not stated
Edward Reynolds Latham & Watkins LLP Associate Capital Markets Not stated
Holly Bauer Latham & Watkins LLP Partner benefits Not stated
Peter Dalmasy Latham & Watkins LLP Associate benefits Not stated
Alyssa Dantoin Latham & Watkins LLP Associate benefits Not stated
Katharine Moir Latham & Watkins LLP Partner tax Not stated
James Aldred Latham & Watkins LLP Associate tax Not stated
Robert Yeh Latham & Watkins LLP Counsel intellectual property Not stated
Andrew Wang Latham & Watkins LLP Associate intellectual property Not stated
Heather Deixler Latham & Watkins LLP Partner data privacy Not stated
Zac Alpert Latham & Watkins LLP Associate data privacy Not stated
Alexandra Gomez Latham & Watkins LLP Associate data privacy Not stated
Betty Pang Latham & Watkins LLP Partner regulatory and healthcare Not stated
Chad Jennings Latham & Watkins LLP Counsel regulatory and healthcare Not stated

14 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 117m (US$116.7 million)
What the figure measures
Issue size
Client
Not stated
Counterparties
TRex Bio, Inc. (Issuer)